Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: A possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors

1. Siendones, E.
2. Barbarroja, N.
3. Torres, L.A.
4. Buendía, P.
5. Velasco, F.
6. Dorado, G.
7. Torres, A.
8. López-Pedrera, C.